ArticleNPJ precision oncology2025

Enhanced patient selection with quantitative continuous scoring of PD-L1 expression for IO treatment in metastatic NSCLC.

J Lesniak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.